Your browser doesn't support javascript.
loading
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials.
Perkovic, Vlado; de Zeeuw, Dick; Mahaffey, Kenneth W; Fulcher, Greg; Erondu, Ngozi; Shaw, Wayne; Barrett, Terrance D; Weidner-Wells, Michele; Deng, Hsiaowei; Matthews, David R; Neal, Bruce.
Affiliation
  • Perkovic V; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia. Electronic address: vperkovic@georgeinstitute.org.au.
  • de Zeeuw D; University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
  • Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA, USA.
  • Fulcher G; Royal North Shore Hospital, University of Sydney, Sydney, NSW, Australia.
  • Erondu N; Janssen Research & Development, Raritan, NJ, USA.
  • Shaw W; Janssen Research & Development, Raritan, NJ, USA.
  • Barrett TD; Janssen Research & Development, Raritan, NJ, USA.
  • Weidner-Wells M; Janssen Research & Development, Raritan, NJ, USA.
  • Deng H; Janssen Research & Development, Raritan, NJ, USA.
  • Matthews DR; University of Oxford, Oxford, UK.
  • Neal B; The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia; Charles Perkins Centre, University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Imperial College London, London, UK.
Lancet Diabetes Endocrinol ; 6(9): 691-704, 2018 09.
Article in En | MEDLINE | ID: mdl-29937267
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Canagliflozin / Sodium-Glucose Transporter 2 Inhibitors / Kidney Diseases Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Lancet Diabetes Endocrinol Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Canagliflozin / Sodium-Glucose Transporter 2 Inhibitors / Kidney Diseases Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Lancet Diabetes Endocrinol Year: 2018 Type: Article